Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 6 Mar 2008 GlaxoSmithKline, Drugs for Neglected Diseases initiative to Collaborate on Research Projects to Meet Public Health Needs in the Developing World
Press releases 6 Mar 2008 Spanish government commits EUR 5 million to DNDi’s research for new medicines for neglected diseases
Press releases 12 Dec 2007 DNDi Receives $25.7M from the Bill & Melinda Gates Foundation to Develop New Medicines for Neglected Diseases
Press releases 5 Nov 2007 The US National Institutes of Health Awards DNDi with a 3-Year Grant Dedicated to the Development of a Low-Cost Treatment for Visceral Leishmaniasis
Press releases 1 Nov 2007 SCYNEXIS and DNDi Enter Landmark Multi-Year Agreement to Identify Drug Candidates to Treat Sleeping Sickness
Press releases 12 Oct 2007 DNDi Executive Team Adds Two New Directors, Including Former Abbott VP Shing Chang as New R&D Director
Press releases 11 Oct 2007 Advinus Therapeutics and DNDi Join Forces on Drug Discovery and Development for Visceral Leishmanias (Kala Azar)
Press releases 13 Jul 2007 DNDi Welcomes Marcel Tanner As Chair of the Board of Directors Along With New Chair of the Scientific Advisory Committee
Press releases 14 Jun 2006 French development agency AFD commits €1.5m to DNDi for the development of two news drugs for malaria
Press releases 8 Feb 2006 Greater EU Leadership Needed to Further Critical Research on Neglected Diseases
Press releases 2 Feb 2006 Experts across Asia meet to discuss a new, soon to be available, fixed-dose malaria treatment
Press releases 14 Dec 2005 Collaboration on the Development of Anti-Parasitic Drugs for Both Malaria and Leishmaniasis
